Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,738,595,894
-$316,629,739 QoQ
Shares Held
22,595,566
-8.8% QoQ
Ownership
0.938%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#13
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. JNJ ranks #4 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
|
64,961,641 | $3,405,289,219 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,738,595,894 | 22,595,566 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,055,225,633 | 24,771,828 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,885,832,060 | 18,776,671 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,492,680,231 | 13,443,427 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,050,130,303 | 13,421,475 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,286,692,633 | 13,788,547 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,325,479,328 | 16,079,929 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,968,440,051 | 18,316,920 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,492,199,296 | 17,051,172 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,669,860,422 | 16,877,555 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,610,447,644 | 16,654,636 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,782,208,195 | 17,863,295 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,459,419,143 | 20,900,309 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,750,894,430 | 17,747,706 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $3,372,630,062 | 19,092,160 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,097,027,068 | 18,958,295 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $3,323,883,446 | 18,725,049 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,746,359,090 | 15,496,017 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,122,660,507 | 12,408,140 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,082,195,597 | 12,892,852 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $2,193,492,505 | 13,314,875 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,143,868,831 | 13,044,532 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,177,891,009 | 13,838,423 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $2,265,381,602 | 15,216,158 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,255,390,187 | 16,037,760 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $2,247,989,911 | 17,143,216 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||